Team

desire

Chris Buyse

Managing Partner

Tel. + 32 (0)16/90 50 01

Chris Buyse was CFO at ThromboGenics NV from September 2006 until June 2014. He has 25 years of experience in international company finance and in running and establishing best financial practice. He was previously CFO of the Belgian biotechnology company CropDesign. Before this, he was Finance Director of WorldCom/MCI Belux, and was CFO and interim CEO of Keyware Technologies, in addition, he held several financial positions at Suez Lyonnaise des Eaux and Unilever. He is currently serving as an independent Board Member of a few companies, mostly active in life sciences such as Celyad, Bone Therapeutics, Iteos and Bioxodes.

desire

Paul Magrez

Partner

Tel + 32 (0)16/90 50 02

Paul MAGREZ holds a M.D. degree and a Ph.D. degree in Medical Computer Sciences both at the ULB (Brussels). He has more than 30 years of experience in in-vitro diagnostics, clinical biology, biotechnology, and pharmaceutical industries. He held several senior and CEO positions at UCB, GlaxoWelcome, GSK, Innogenetics, Theradiag and Cerba European Lab. In 2011, he founded his own consulting firm in support of SMEs and start-ups.

desire

Philippe Monteyne

Partner

Tel +32 (0)16/90 50 03

Philippe MONTEYNE holds an M.D. degree trained as a Neurologist and a Ph.D. in Viral Immunology, both at the UCL (Univ. Cathol. de Louvain), followed by a post-doctoral fellowship at Pasteur Institute, Paris. During the last 20 years, he held senior positions in top pharma companies such as SmithKline Beecham, GSK Biologicals (as Head of Global Vaccine Development) and GSK Rare Diseases (Head of Development and Chief Medical Officer) and SANOFI (Vice President R&D France). He is also currently member of different Strategic Advisory Committees. He is also visiting Professor of Neurology at the UCL.

desire

Jan Van den Bossche

Partner

Tel +32 (0)16/90 50 04

Jan Van den Bossche holds a Master Degree in Applied Economic Sciences at the KULeuven. He worked for more than 12 years as a biotech analyst at Petercam. He was involved in numerous public and private transactions of Belgian and Dutch Biotech companies, such as ThromoboGenics, Tigenix, UCB, AMT (Uniqure), IBA, MDxHealth . Before he joined Fund+, he was for more than 2 years part of the investor relations team at the Dutch life sciences and materials sciences company DSM (Geleen, NL).


diane_dewyngaert

Diane De Wyngaert

Administrative Assistant

Diane holds a bachelor degree in informatics. She joined Life Sciences Research Partners in 2007 as administrative assistant, where she still is in charge of the Administration, Human Resources and Bookkeeping. Diane joined Fund+ from the start-up.